Skip to main content

Table 2 Summary of different types of statin treatments in type 2 diabetes patients (T2D) and patients without diabetes (No T2D)

From: Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events

  All No T2D (n = 129) T2D (n = 71)
Simvastatin, n (high/intermediate/low dose) 137 (76/52/9) 88 (44/37/7) 49 (32/15/2)
Pravastatin, n (high/intermediate/low dose) 7 (4/3/0) 5 (2/3/0) 2 (2/0/0)
Atorvastatin, n (high/intermediate/low dose) 16 (2/4/10) 7 (1/3/3) 9 (1/1/7)
Rosuvastatin, n (high/intermediate/low dose) 4 (1/1/2) 0 (0/0/0) 4 (1/1/2)
  1. Statin treatments were divided into low, intermediate or high dose accordingly: Simvastatin (10 mg, 20–30 mg, 40 mg), Pravastatin (10 mg, 20 mg, 40 mg), Atorvastatin (10–30 mg, 40 mg, 80 mg) and Rosuvastatin (5–10 mg,  > 10–20 mg,  > 20–40 mg)